March 01, 2007
Woodcock named to new position at FDA
Janet Woodcock was named to a newly created position as FDA chief medical officer in a management reshuffle that brings in John Dyer to hold her previous titles.
Pharma companies are likely to put up aggressive resistance to the measure, introduced earlier this month.
The pace may even pick up again this year.
The research will also cover topics including disease awareness ads.